Brief International Cognitive Assessment for MS (BICAMS) and NEDA maintenance in MS patients: a 2-years follow-up longitudinal study presentato da Dr. Maria Cellerino

Characterizing diffuse and focal grey matter damage with soma and neurite density image metrics in multiple sclerosis presentato da Dr. Caterina Lapucci

Understanding the interplay between multiple sclerosis patterns and ovarian reserve presentato da Dr. Tommaso Sirito

Efficacy and safety od ocrelizumab in a four-year follow-up cohort of RR-MS patients presentato da Dr. Nicola Cavalli

A real-life, multicenter, observational study to evaluate safety and efficacy of the switch from alemtuzumab to ocrelizumab in MS patients with evidence of disease activity/progression after two alemtuzumab courses: the Italian experience

Lapucci C., Frau J., Cocco E., Coghe G., Petracca M., Lanzillo R., Vercellino M., Cavalla P., Bianco A., Mirabella M., Di Mauro G., Landi D., Marfia G., Torri Clerici V., Tomas E., Ferrò M.T., Grossi P., Zaffaroni M., Ronzoni M., Nozzolillo A., Moiola L., Pinardi F., Novi G., Cellerino M., Uccelli A., Inglese M

Impact of autologous hematopoietic stem cell transplantation on retinal atrophy in multiple sclerosis

Cellerino M., Boffa G., Sirito T., Boccia VD.

The effect of cladribine and fingolimod treatments on retinal atrophy: preliminary findings

Cellerino M., Sirito T., Boccia VD., Laroni A., Lapucci C., Boffa G., Inglese M.

Paramagnetic Rim Lesions Frequency in Pediatric and Adult
Multiple Sclerosis Patients with Similar Disease Duration

Boccia VD., Cellerino M., Lapucci C., Falcitano L., Mancardi MM., Costagli M., Boffa G., Inglese M.